If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

  • There is currently no data for DEMG

Director/PDMR Shareholding

19 Jun 2014 11:00

RNS Number : 0306K
Deltex Medical Group PLC
19 June 2014
 

Deltex Medical Group plc("Deltex Medical" or "the Company")

Director/PDMR Share Dealing

19 June 2014 - Deltex Medical Group (AIM: DEMG), the global leader in oesophageal Doppler monitoring, announces that it has been notified that Paul Mitchell, Finance Director transferred a total of 86,750 ordinary shares of 1p each in the Company ("Ordinary Shares") into his Self Invested Personal Pension on 18 June 2014. This was effected by way of a sale of 86,750 Ordinary Shares held by Paul Mitchell at a price of 10.50 pence per Ordinary Shares. His pension fund then purchased 86,750 Ordinary Shares at a price of 10.55 pence per Ordinary Shares.

As a result of this transaction, Paul Mitchell's total beneficial holding remains unchanged at 352,831 Ordinary Shares representing 0.17% of the total issued ordinary share capital of the Company.

For further information, please contact:

Deltex Medical Group plc

01243 774 837

Nigel Keen, Chairman

investorinfo@deltexmedical.com

Ewan Phillips, Chief Executive

Paul Mitchell, Finance Director

Nominated Adviser & Broker

Arden Partners plc

020 7614 5900

Chris Hardie

Joint Broker

Zeus Capital Limited

020 7533 7727

Dominic Wilson

John Goold

Financial Public Relations

Newgate Threadneedle

020 7653 9850

Caroline Forde

Heather Armstrong

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLIFEARSIALIS
Date   Source Headline
22nd Jan 20207:00 amRNSPre-close statement and trading update
18th Dec 20197:00 amRNSDirector Dealing
13th Dec 201910:34 amRNSExercise of Options
27th Nov 201911:34 amRNSExercise of Options
20th Nov 20197:30 amRNSFinance Director Appointed
14th Nov 20192:54 pmRNSExercise of Options
18th Oct 201911:54 amRNSExercise of Options
10th Oct 20197:31 amRNSInnovate UK Smart Award granted
7th Oct 20197:00 amRNSDirectorate Change
24th Sep 201911:30 amRNSHolding(s) in Company
23rd Sep 20192:26 pmRNSExercise of Options
23rd Sep 20197:00 amRNSInterim Results
13th Sep 201910:37 amRNSHolding(s) in Company
11th Sep 20192:52 pmRNSHolding(s) in Company
11th Sep 20197:00 amRNSNotice of Interim Results
9th Sep 20191:15 pmRNSExercise of Options
22nd Aug 201910:45 amRNSExercise of Options
30th Jul 20197:00 amRNSPre-close Trading Update
23rd Jul 201911:21 amRNSExercise of Options
2nd Jul 20199:00 amRNSEDM+ Innovative Technology Contract from Vizient
4th Jun 20197:00 amRNSHolding(s) in Company
22nd May 201911:59 amRNSResult of AGM
22nd May 20197:00 amRNSChairman's Statement to Annual General Meeting
13th May 20191:55 pmRNSHolding(s) in Company
13th May 20197:00 amRNSExercise of Options
3rd May 20191:57 pmRNSTurner Pope Investor Evening
1st May 20194:47 pmRNSAnnual Report and Notification of AGM
1st May 20193:16 pmRNSAnnual Report and Notification of AGM
25th Apr 20197:00 amRNSResults for the year ended 31 December 2018
10th Apr 201911:10 amRNSNotice of Annual Results
6th Feb 20197:00 amRNSHolding(s) in Company
5th Feb 20198:58 amRNSDirector Dealing
29th Jan 20194:11 pmRNSExercise of Options
25th Jan 20197:00 amRNSPre-close statement and trading update
26th Nov 20181:08 pmRNSChange of Auditor
26th Sep 20188:16 amRNSHolding(s) in Company
24th Sep 20187:00 amRNSInterim results
18th Sep 20187:00 amRNSNotice of Results
28th Aug 20187:00 amRNSDirector Dealing
23rd Aug 201812:50 pmRNSDirector Dealing
6th Aug 20184:45 pmRNSGrant of Options - Correction
6th Aug 20187:00 amRNSGrant of options
30th Jul 20189:05 amRNSDirector Dealing
27th Jul 201811:35 amRNSHolding(s) in Company
27th Jul 201810:52 amRNSDirector/PDMR Shareholding
25th Jul 20187:00 amRNSPre-close Trading Update
20th Jun 201812:01 pmRNSResult of AGM
20th Jun 20187:00 amRNSChairman's Statement to Annual General Meeting
13th Jun 20187:00 amRNSDirectorate change: Appointment of new CEO
18th May 20187:00 amRNSPartial redemption of convertible loan note

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.